MEARINI, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 8.960
EU - Europa 8.279
AS - Asia 5.776
SA - Sud America 1.047
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 9
Totale 24.226
Nazione #
US - Stati Uniti d'America 8.729
SG - Singapore 2.480
IT - Italia 1.748
UA - Ucraina 1.499
SE - Svezia 1.199
IE - Irlanda 1.098
HK - Hong Kong 981
RU - Federazione Russa 864
BR - Brasile 814
CN - Cina 763
VN - Vietnam 545
DE - Germania 446
FR - Francia 410
FI - Finlandia 356
KR - Corea 265
GB - Regno Unito 264
CA - Canada 150
IN - India 149
TR - Turchia 137
AR - Argentina 84
BD - Bangladesh 63
CH - Svizzera 63
IQ - Iraq 62
NL - Olanda 60
PK - Pakistan 56
PL - Polonia 54
BE - Belgio 42
MX - Messico 41
UZ - Uzbekistan 41
EC - Ecuador 37
ID - Indonesia 36
CO - Colombia 35
ZA - Sudafrica 33
AT - Austria 31
ES - Italia 31
SA - Arabia Saudita 30
JP - Giappone 28
VE - Venezuela 25
LB - Libano 22
MA - Marocco 22
MY - Malesia 20
GR - Grecia 19
RO - Romania 18
TN - Tunisia 17
PY - Paraguay 16
PH - Filippine 15
CZ - Repubblica Ceca 14
EU - Europa 14
CL - Cile 13
EG - Egitto 13
LT - Lituania 12
JO - Giordania 11
UY - Uruguay 11
DZ - Algeria 10
ET - Etiopia 10
NP - Nepal 9
AL - Albania 8
BG - Bulgaria 8
DO - Repubblica Dominicana 8
JM - Giamaica 8
AU - Australia 7
BO - Bolivia 7
KE - Kenya 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
KZ - Kazakistan 6
HR - Croazia 5
IL - Israele 5
KG - Kirghizistan 5
OM - Oman 5
SN - Senegal 5
SY - Repubblica araba siriana 5
NO - Norvegia 4
PA - Panama 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BH - Bahrain 3
DK - Danimarca 3
GE - Georgia 3
GH - Ghana 3
HU - Ungheria 3
KH - Cambogia 3
NG - Nigeria 3
PE - Perù 3
PS - Palestinian Territory 3
TH - Thailandia 3
AZ - Azerbaigian 2
BB - Barbados 2
BF - Burkina Faso 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
HN - Honduras 2
IR - Iran 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
MZ - Mozambico 2
PT - Portogallo 2
Totale 24.191
Città #
Singapore 1.646
Chandler 1.313
Dublin 1.093
Hong Kong 977
Jacksonville 751
San Mateo 737
San Jose 612
Ashburn 448
Boardman 425
Santa Clara 315
Medford 282
Princeton 281
Moscow 268
Seoul 264
Lauterbourg 238
Dong Ket 227
Wilmington 218
Altamura 173
Andover 157
Ann Arbor 153
Beijing 151
Des Moines 142
Perugia 138
Lawrence 126
Ho Chi Minh City 114
Rome 114
Los Angeles 97
Piscataway 97
Ottawa 89
Izmir 83
New York 82
Saint Petersburg 80
Munich 79
Shanghai 76
Hanoi 74
São Paulo 68
Milan 66
The Dalles 62
Norwalk 61
Woodbridge 54
Helsinki 44
Orem 44
Brussels 41
Frankfurt am Main 40
Turku 39
Florence 38
Houston 37
Chennai 36
Redwood City 36
Falls Church 32
Brooklyn 31
Montreal 31
Rio de Janeiro 30
Baghdad 29
Warsaw 29
Tashkent 27
Tokyo 27
Redmond 26
Stockholm 26
Chicago 25
Council Bluffs 24
Belo Horizonte 22
San Paolo di Civitate 22
Dallas 21
Columbus 19
Johannesburg 19
Philadelphia 19
Manchester 18
Palermo 18
Amsterdam 17
Auburn Hills 17
Istanbul 17
Bari 16
London 16
Bucharest 15
Dearborn 15
Den Haag 15
Denver 15
Haiphong 15
Kuala Lumpur 15
Atlanta 14
Curitiba 14
Dhaka 14
Bologna 13
Brasília 13
Da Nang 13
Genoa 13
Guangzhou 13
Paris 13
Quito 13
Riyadh 13
Boston 12
Changsha 12
Medellín 12
Nuremberg 12
Phoenix 12
Toronto 12
Turin 12
Basingstoke 11
Campinas 11
Totale 13.706
Nome #
CROMOGRANINA A NELLE PATOLOGIE PROSTATICHE 683
Ruolo dell’ecografia nella valutazione delle complicanze della chirurgia pelvica con impiego di protesi 275
ABDOMINAL VS LAPAROSCOPIC SACROPEXY: SUBGROUP ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL 270
Infiltrazione intraprostatica ecoguidata nella prostatite cronica 197
Utilizzo degli alfa-litici nelle donne con sintomi del basso tratto urinario 195
Abdominal surgery for uterovaginal prolapse: sacropexy vs hysterocolposacropexy 166
Pros-IT CNR: an Italian prostate cancer monitoring project 160
Malattia di La Peyronie: Corporoplastica con patch di mucosa buccale 158
Bacillus Calmette-Guérin versus Gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study 158
Assessing outcome after a modified vaginal wall sling for stress incontinence with intrinsic sphincter deficiency 155
RUOLO DELLA COLPOSACROPESSIA LAPAROSCOPICA NELLA CORREZIONE DEL PROLASSO UROGENITALE RECIDIVO DOPO FALLIMENTO DI CHIRURGIA TRANVAGINALE CON MESH 145
Abdominal pelvic floor reconstruction with uterus preservation 139
Anatomia del rene, delle vie urinarie e dell'apparato genitale maschile: Pelvi-Perineo-Apparato di sostegno 138
Evaluation of Prostate-Specific Antigen Isoform p2PSA and Its Derivates, %p2PSA, Prostate Health Index and Prostate Dimension-Adjusted Related Index in the Detection of Prostate Cancer at First Biopsy: An Exploratory, Prospective Study. 138
ABDOMINAL HYSTEROCOLPOSACROPEXY: A PROSPECTIVE LONG TERM STUDY 137
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 136
Body Mass Index e sintomatologia urinaria nella donna 135
Nested Type Bladder Cancer: A Tricky Entity A Report of Two Cases 132
Effects of Botulinum-A toxin intravesical injections on bladder hypersensitive disorders: a pilot study 131
Assessment of bladder and urethral sphincter function before and after radical retropubic prostatectomy. 129
Efficacia e tollerabilità della Solifenacina Succinato nella terapia della vescica iperattiva: risultati a breve termine 127
Is surgical outcome at risk during post-graduated educational courses for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) repair? A case control study 127
Adrenal oncocytic neoplasm: a systematic review 127
Clinical staging accuracy of renal tumors 126
Conformal Postoperative Radiotherapy in Patients With Positive Resection Margins and/or pT3-4 Prostate Adenocarcinoma. 126
Abdominal sacropexy with uterine conservation for women with uterovaginal prolapse: an evolving concept 125
Long-term outcome of anti-incontinence procedure during Pelvic Organ Prolapse repair in patients with or without urinary incontinence: results from two randomized surgical trials 125
ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL, FINAL RESULTS 125
Biparametric versus Multiparametric MRI with Non-endorectal Coil at 3T in the Detection and Localization of Prostate Cancer 125
Bladder and urethral sphincter function after radical prostatectomy: long term follow up. 124
Master di II livello in uroginecologia: quali i risultati chirurgici 124
Association of CYP17, GSTP1, PON1-55 and PON1-192 polymorphisms with prostate cancer risk 124
Induratio penis plastica: corporoplastica con innesto di mucosa buccale 124
Prulifloxacin vs Phosphomycin: Prophylaxis in patients with recurrent UTI. Preliminary results of a randomized multi-centre study 122
Associazione tra polimorfismo di Cyp17, GSTP1, PON1-55 e PON1-192 e rischio di carcinoma prostatico 121
Leiomioma mixoide vaginale parauretrale 120
Il Q-tip test vs ecografia nella diagnosi di ipermobilità uretrale: nostra esperienza 117
A review of penile metastasis 117
Valutazione ecografica del deficit sfinterico uretrale: nostra esperienza 116
Uterus preservation vs hysterectomy during sacropexy 116
Associazione tra polimorfismo di CYP17, GSTP1, PON1-55-192 e rischio di carcinoma prostatico 115
Body mass Index and urinary symptoms in women 114
La colposospensione associata a Ricostruzione integrale del pavimento pelvico. 113
Diagnosi ecografica di iperattività detrusoriale: nostra esperienza 112
Correlation between age and Chromogranin A determination in prostate diseases 112
Stage pT1 renal cell carcinoma: review of the prognostic significance of size 111
Sacropexy with uterine conservation: results after 5 years 111
Alpha lithic agents for women with lower urinary tract symptoms. 110
Long-Term follow-up uterus sparing surgery for pelvic organ prolapse (POP) 109
Outcomes of radical prostatectomy in clinically locally advanced N0M0 prostate cancer 109
Overactive bladder symptoms (OAB) and detrusor overactivity (DO) in patients with posterior vault prolapse: Prevalence and its changes after POP repair 108
Risultati a lungo termine di uno studio randomizzato controllato TOT VS TVT 108
Abdominal vs Laparoscopic sacrocolpopexy a subanalysis of a randomized controlled trial. 108
TGF-Beta and prostate cancer: a reliable marker? 108
Sindrome uretrale: quale trattamento? 107
A PROSPECTIVE RANDOMIZED TRIAL: ABDOMINAL VS LAPAROSCOPIC SACROPEXY FOR ADVANCED PELVIC ORGAN PROLAPSE 107
Carcinoma renale stadio pT1: revisione del significato prognostico delle dimensioni 106
Elective consevative surgery and renal tumour multifocality: our experience 106
A prospective randomised trial comparing tension-free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence 106
Prostasomes and prostate cancer. 106
Female sexual dysfunction in urogenital prolapse surgery: colposacropexy vs hysterocolposacropexy 105
PUMA vs Romanzi in the detection of female bladder obstruction and detrusor contractility 105
Penile Prosthesis implantation and couple’s satisfaction 105
Studio randomizzato colposacropessia laparoscopica versus colposacropessia robot-assistita: due tecniche miniinvasive a confronto 104
ASAP e carcinoma prostatico 102
Il test pubo-coccigeo: correlazioni cliniche e urodinamiche 102
Bcg vs. Gemcitabina per la terapia endovescicale del carcinoma uroteliale ad alto rischio: Studio prospettico randomizzato 102
A SUBANALYSIS OF A RANDOMIZED CONTROLLED TRIAL: ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY 102
Trattamento del varicocele: studio prospettico randomizzato tra chirurgia a cielo aperto (approccio inguinale) vs scleroterapia anterograda sec. Tauber 101
Impact of catheter size on Pressure/Flow results in women 100
High intensity focused ultrasound (HIFU) con visualizzazione trans rettale real time mediante Sonablate 500 per il trattamento della recidiva dopo HIFU primaria 100
Alpha lithic agents in women 100
Testosterone levels in benign prostatic hypertrophy and prostate cancer 99
COLPOSACROPESSIA ADDOMINALE: CAMBIANO I RISULTATI A LUNGO TERMINE? 99
Uretriti e malattie sessualmente trasmesse 98
Cut-off values to define bladder outlet obstruction (BOO) in women 98
Low serum testosterone levels are predictive of prostate cancer. 98
Diagnosing detrusor contractility in men with benign prostatic hypertrophy 97
Preservazione dell'utero o isterectomia nella sacropessia: due tecniche a confronto 97
The S.A.C.S. (Safety–Anatomy–Continence–Satisfaction) score in evaluating P.O.P. (Pelvic Organ Prolapse)surgery: a proposal 97
Perineografia: nuova indagine in uroginecologia? 96
Intermittent androgen suppression in prostate cancer: really intermittent? 96
Female sexual function evaluation in patients who underwent integral pelvic floor reconstructive surgery 96
Isterocolposacropessia:confronto tra videolaparoscopia e chirurgia open 96
ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL 96
Echo-color doppler in the diagnosis of vascular abnormalities associated with ureteropelvic junction obstruction 95
Tension-free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial 95
Chirurgia del prolasso con preservazione dell’utero: risultati a lungo termine 95
Vescica Neurologica e sindrome di Klippel-Trenaunay-Weber 95
POLYVINYLIDENFLUORID (PVDF) VERSUS POLYPROPYLENE MESH FOR SACROCOLPOPEXY 95
Surgical personal technique for an orthotopic ileal neo-bladder reconstruction: long term functional results 95
Prostatiti e disturbi correlati 93
Colposacropexy vs hysterocolposacropexy 93
Ricostruzione integrale del pavimento pelvico 93
Surgical correction of uro-genital prolapse: A randomized trial of open surgery vs laparoscopy. Preliminary report 93
Prospective randomized trial comparing abdominal vs laparoscopic sacropexy for the treatment of advanced pelvic organ prolapse 93
Impact of different sized catheters on pressure-flow studies in women with lower urinary tract symptoms 92
Valutazione ecografica delle pazienti sottoposte ad intervento di correzione della statica pelvica con impiego di protesi 92
Recovery of sexual function after nerve-sparing radical retropubic prostatectomy: is cavernous nitric oxide level a prognostic index? 92
Perugia orthotopic neobladder after seminal-vescicle/prostate sparing cystectomy: a complete recovery of sexual function and body image 92
Totale 12.315
Categoria #
all - tutte 99.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021703 0 0 0 0 0 0 0 0 0 131 267 305
2021/20222.764 64 596 76 230 110 40 72 727 46 44 312 447
2022/20234.173 362 602 81 316 339 493 25 255 1.454 35 145 66
2023/20241.725 112 167 97 36 29 44 396 117 252 43 200 232
2024/20253.283 76 399 123 98 464 118 45 244 609 170 639 298
2025/20266.589 550 465 359 950 787 545 1.196 326 802 609 0 0
Totale 24.659